Market news

SAN DIEGO, CA / ACCESS Newswire / September 8, 2026 / ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch pump, today announced that its Chief Executive Officer, Jeb Besser, will present and host one-on-one meetings at the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026.iAccess Alpha Virtual Conference Details: Dates: September 15-16, 2026 Presentation

SAN DIEGO, CA / ACCESS Newswire / September 4, 2026 / ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the commercial launch of its next-generation Pivot™ tubeless patch pump, today announced that it has secured a contract with a national U. pharmacy benefit manager (PBM) in the United States.

Clearance Covers Software Enhancements for Greater Patient Flexibility and Pivot CustomizationSAN DIEGO, CA / ACCESS Newswire / September 3, 2026 / ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch pump, today announced that the U. Food & Drug Administration (FDA) has cleared a set of software enhancements to its Pivot insulin delivery system, further expanding the sy

Modular Medical, Inc. (NASDAQ:MODD) on Thursday announced that the U.S. Food & Drug Administration (FDA) has cleared a set of software enhancements to its Pivot insulin delivery system. The update further expands the system’s functionality and provides users with greater flexibility and customization options in bolus dosing, an enhanced user interface (UI), and other software upgrades. In July, the company submitted to the FDA a series of software enhancements to its Pivot insulin delivery syste

* Meet with Modular Medical CEO Jeb Besser. * Discover The Pivot tubeless patch pump, a simple, wearable insulin delivery platform designed to provide continuous subcutaneous insulin infusion with both basal and bolus insulin delivery over a three-day wear period.

SAN DIEGO, CA / ACCESS Newswire / August 5, 2026 / Modular Medical, Inc ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch ...

First Phase of Strategic Rollout Targets Markets with Leading Insulin Pump Prescribers and Strong New Pump Adoption. Inizio will Provide Commercialization Expertise to Accelerate Awareness and Adoption of the Pivot Pump. SAN DIEGO, CA / ACCESS Newswire ...

- Council to Provide Strategic Clinical Guidance on Commercialization, Patient Identification, Workflow Integration, and Evidence Generation SAN DIEGO, CA / ACCESS Newswire / July 23, 2026 / Modular Medical, Inc, ("Modular Medical" or "the Company") ...

Pilot Combines Clinician Guided Phenotypes with IMO Health's Unique Terminology Identifiers to Help Clinicians Easily Identify Patients Most Likely to Benefit from Pivot Insulin Pump Therapy Advancing Towards Fourth Quarter Commercial Launch of Pivot ...

Completed Independent Study Strongly Supports Favorable Payor Receptivity to Pivot's Differentiated Design and Simplified User Experience, and provides further validation of significant progress towards goal of achieving broad market access for Pivot ...

97% of Surveyed Injection Users Would Consider Pump Therapy - if Easier to Learn and Improved Outcomes Conducting Additional Research Initiative in Conjunction with Commercialization of the Pivot Tubeless Insulin Patch Pump Company to Showcase Pivot ...